Literature DB >> 10543563

Minimally invasive direct coronary artery bypass combined with abdominal aortic aneurysm repair.

Y Kameda1, S Taniguchi, T Kawata, N Tabayashi, M Kimura.   

Abstract

BACKGROUND: For simultaneously combined coronary artery bypass surgery with infrarenal abdominal aortic aneurysm (AAA) repair, a relatively high operative mortality and morbidity have been reported.
METHODS: From February 1998 to December 1998, simultaneous minimally invasive direct coronary artery bypass combined with the AAA repair was performed for 4 patients (3 males, 1 female; mean age, 74+/-7 years). Three were high-risk patients: 2 were over 75 years of age, 2 had respiratory insufficiency, and 1 had severe renal impairment.
RESULTS: There were no mortalities. The endotracheal tube was removed within approximately 12 hours, and the postoperative courses were uneventful. During 4+/-4 months of follow-up, there was neither angina recurrence nor other morbidity.
CONCLUSIONS: Minimally invasive direct coronary artery bypass combined with AAA repair was safe even for high-risk patients.

Entities:  

Mesh:

Year:  1999        PMID: 10543563     DOI: 10.1016/s0003-4975(99)00965-0

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

Review 1.  Coronary artery bypass grafting without full sternotomy.

Authors:  Hideki Sasaki
Journal:  Surg Today       Date:  2009-11-01       Impact factor: 2.549

2.  Off-pump coronary artery bypass combined with abdominal aortic aneurysm repair in an 88-year-old male.

Authors:  Toshihiro Ohata; Nobuo Sakagoshi; Harumasa Yasuda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2005-01

3.  Simultaneous operation of ischemic heart disease, abdominal aortic aneurysm, and rectal cancer.

Authors:  Takayoshi Kato; Hisato Takagi; Yoshio Mori; Ken-ichi Sakamoto; Takuya Yamada; Yukio Umeda; Yukiomi Fukumoto; Hajime Hirose
Journal:  Heart Vessels       Date:  2005-07       Impact factor: 2.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.